[{"address1": "1210-1220 Washington St.", "address2": "Suite 210", "city": "Newton", "state": "MA", "zip": "02465", "country": "United States", "phone": "617 344 4190", "website": "https://acumenpharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize Sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel J. O'Connell M.B.A.", "age": 53, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 1043294, "exercisedValue": 0, "unexercisedValue": 3599341}, {"maxAge": 1, "name": "Mr. Matt  Zuga", "title": "CFO & Chief Business Officer", "fiscalYear": 2023, "totalPay": 702601, "exercisedValue": 0, "unexercisedValue": 884506}, {"maxAge": 1, "name": "Mr. Derek M. Meisner Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 752945, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Doherty Ph.D.", "age": 56, "title": "President & Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Grant A. Krafft Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "totalPay": 42000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Caleb E. Finch Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William L. Klein Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Barton M.S.", "age": 65, "title": "Chief Operating Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 223680, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Carranza", "title": "Vice President, Finance & Accounting and Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alex  Braun M.B.A.", "title": "VP & Head of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.02, "open": 1.01, "dayLow": 0.995, "dayHigh": 1.12, "regularMarketPreviousClose": 1.02, "regularMarketOpen": 1.01, "regularMarketDayLow": 0.995, "regularMarketDayHigh": 1.12, "payoutRatio": 0.0, "beta": 0.098, "forwardPE": -0.7254902, "volume": 145860, "regularMarketVolume": 145860, "averageVolume": 258000, "averageVolume10days": 274840, "averageDailyVolume10Day": 274840, "bid": 1.07, "ask": 1.15, "bidSize": 1, "askSize": 1, "marketCap": 67236472, "fiftyTwoWeekLow": 0.902, "fiftyTwoWeekHigh": 3.92, "fiftyDayAverage": 1.2605, "twoHundredDayAverage": 2.1482, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -82620248, "profitMargins": 0.0, "floatShares": 32793241, "sharesOutstanding": 60573400, "sharesShort": 1775675, "sharesShortPriorMonth": 1744166, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0295, "heldPercentInsiders": 0.11145, "heldPercentInstitutions": 0.75939006, "shortRatio": 8.97, "shortPercentOfFloat": 0.0397, "impliedSharesOutstanding": 60573400, "bookValue": 3.026, "priceToBook": 0.3668209, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -102329000, "trailingEps": -1.71, "forwardEps": -1.53, "enterpriseToEbitda": 0.725, "52WeekChange": -0.6855524, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 1.11, "targetHighPrice": 11.0, "targetLowPrice": 4.0, "targetMeanPrice": 9.2, "targetMedianPrice": 10.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 171556992, "totalCashPerShare": 2.832, "ebitda": -113954000, "totalDebt": 29702000, "quickRatio": 6.237, "currentRatio": 6.459, "debtToEquity": 16.336, "returnOnAssets": -0.25955, "returnOnEquity": -0.45602, "grossProfits": -93798000, "freeCashflow": -52293124, "operatingCashflow": -86215000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ABOS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1625146200000, "postMarketChangePercent": -0.9009, "postMarketPrice": 1.1, "postMarketChange": -0.00999999, "regularMarketChange": 0.09000003, "regularMarketDayRange": "0.995 - 1.12", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 258000, "fiftyTwoWeekLowChange": 0.208, "fiftyTwoWeekLowChangePercent": 0.23059867, "fiftyTwoWeekRange": "0.902 - 3.92", "fiftyTwoWeekHighChange": -2.81, "fiftyTwoWeekHighChangePercent": -0.7168367, "fiftyTwoWeekChangePercent": -68.555244, "earningsTimestamp": 1743073200, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "earningsCallTimestampStart": 1743076800, "earningsCallTimestampEnd": 1743076800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.71, "epsForward": -1.53, "epsCurrentYear": -2.31978, "priceEpsCurrentYear": -0.47849363, "fiftyDayAverageChange": -0.15049994, "fiftyDayAverageChangePercent": -0.11939702, "twoHundredDayAverageChange": -1.0382, "twoHundredDayAverageChangePercent": -0.48328835, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-01", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Acumen Pharmaceuticals, Inc.", "longName": "Acumen Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1744415816, "regularMarketTime": 1744401601, "exchange": "NMS", "messageBoardId": "finmb_8539521", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 8.823533, "regularMarketPrice": 1.11, "displayName": "Acumen Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]